Everolimus-eluting stents are largely used for left main (LM) percutaneous coronary interventions (PCI). Long-term follow-up of patients who underwent LM PCI in a real world clinical setting, in particular women, have been scarcely reported. Consecutive patients who underwent unprotected LM PCI with EES at a single Institution from December 2006 to April 2016 were included. Main outcome assessed was the occurrence of major adverse cardiovascular events (MACE) as a composite of death, myocardial infarction or target lesion revascularization at follow-up. Overall, 589 patients (20.8% women) were included in the present analysis. Women were older, had lower body mass index and more frequently hypertensive compared with men. Main clinical presentation was stable coronary artery disease (CAD); unstable angina was more frequently observed in women compared with men, whereas ST-elevation myocardial infarction was less frequent. After 69.7 ± 28.3 months of follow-up, 47 patients overall experienced MACE (1.43 per 100*patients/year). MACE rate was higher in women compared with male patients, with a rate of 2.49 and 1.17 per 100*patients/year, respectively (p = 0.015). The difference was driven mainly by higher mortality in women (0.89 vs 0.15 per 100*patients/years, p = 0.002). At multivariable Cox regression, female gender was independently associated with an increased risk of MACE at follow-up (hazard ratio 2.21, 95% confidence interval 1.20 to 4.08, p = 0.011). In conclusion, EES can be safely and effectively adopted for LM PCI.
Comparison of the Effectiveness of Percutaneous Intervention of the Left-main Coronary Artery with Everolimus-eluting Stents in Women -vs- Men / D. Trabattoni, G. Teruzzi, P. Montorsi, F. Fabbiocchi, S. Gili, G. Calligaris, L. Grancini, S. Galli, P.M. Ravagnani, A. Bartorelli. - In: THE AMERICAN JOURNAL OF CARDIOLOGY. - ISSN 0002-9149. - 124:9(2019 Nov 01), pp. 1357-1362.
|Titolo:||Comparison of the Effectiveness of Percutaneous Intervention of the Left-main Coronary Artery with Everolimus-eluting Stents in Women -vs- Men|
|Parole Chiave:||Left main; percutaneous coronary interventions; everolimus eluting stents; gender medicine; coronary artery disease.|
|Settore Scientifico Disciplinare:||Settore MED/11 - Malattie dell'Apparato Cardiovascolare|
|Data di pubblicazione:||1-nov-2019|
|Digital Object Identifier (DOI):||http://dx.doi.org/10.1016/j.amjcard.2019.07.060|
|Appare nelle tipologie:||01 - Articolo su periodico|